Antibody-engineered drugs

Author: Zhen Yongsu
Publisher:
Publish Date: 2002-11-01
Features: "The Modern Biotechnology Pharmaceutical Series" is a premium book series meticulously planned and launched by Chemical Industry Press. This series is chaired by Academician Zhen Yongsu, a renowned expert in biomedicine and pharmaceuticals in China, with contributions from experts in relevant fields. "Antibody Engineering Drugs" is written by experts who have long been engaged in research and application in the field, including 2 academicians from the Chinese Academy of Engineering and 1 academician from the Chinese Academy of Sciences. This book summarizes their extensive research experience and achievements. It begins with antibody engineering, introducing hybridoma cell technology, monoclonal antibodies, genetic engineering antibodies, antibody library technology, antibody production using animal cells and transgenic animals, as well as antibody isolation and purification techniques. It then covers antibody immunoconjugates, antibody-based fusion proteins, enzyme-related antibody drugs, in vitro applications of antibodies, antibody pharmacokinetics, and radioimmunoimaging and therapy. Finally, it elaborates on the application of antibodies and antibody engineering drugs in the treatment of tumors, cardiovascular diseases, viral infections, immune system-related diseases, and gene therapy. It is a systematic and comprehensive work that integrates theory with practice, focusing on practical techniques. This book is suitable for biomedicine research and technical personnel, as well as students and teachers from relevant disciplines at colleges and universities for reference.